McFarland, James M. http://orcid.org/0000-0001-9978-480X
Paolella, Brenton R. http://orcid.org/0000-0003-3394-828X
Warren, Allison
Geiger-Schuller, Kathryn http://orcid.org/0000-0002-6705-0681
Shibue, Tsukasa
Rothberg, Michael
Kuksenko, Olena
Colgan, William N. http://orcid.org/0000-0002-8328-4672
Jones, Andrew
Chambers, Emily
Dionne, Danielle
Bender, Samantha
Wolpin, Brian M.
Ghandi, Mahmoud http://orcid.org/0000-0003-1897-2265
Tirosh, Itay
Rozenblatt-Rosen, Orit
Roth, Jennifer A.
Golub, Todd R. http://orcid.org/0000-0003-0113-2403
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Aguirre, Andrew J. http://orcid.org/0000-0002-0701-6203
Vazquez, Francisca http://orcid.org/0000-0002-2857-4685
Tsherniak, Aviad http://orcid.org/0000-0002-3797-1877
Article History
Received: 7 February 2020
Accepted: 26 June 2020
First Online: 27 August 2020
Competing interests
: A.R. is a co-founder and equity holder of Celsius Therapeutics, equity holder in Immunitas, and an SAB Member of ThermoFisher Scientific, Neogene Therapeutics, Asimov, and Syros Pharmaceuticals. A.J.A. has consulted for Oncorus, Inc., Arrakis Therapeutics, and Merck & Co., Inc. and has research funding from Mirati Therapeutics and Deerfield Management that are unrelated to this work. A.T. is a consultant for Tango Therapeutics. T.R.G. is a consultant to GlaxoSmithKline, a founder of Sherlock Biosciences, and was formerly a consultant and equity holder in Foundation Medicine, acquired by Roche. T.R.G. also receives research funding unrelated to this project from Bayer Healthcare. B.M.W. receives research funding unrelated to this project from Celgene and Lilly and is a consultant for BioLineRx, Celgene, G1 Therapeutics, and GRAIL. The Broad Institute filed a United States Provisional Patent Application directed to work described in this article. The pending Application is entitled “Rapid Prediction of Drug Responsiveness” and was filed on September 2, 2019. The current inventor list includes A.T., A.J.A., F.V., B.R.P., and J.M.M. A.W., K.G.-S., T.S., M.R., O.K., W.N.C., A.J., E.C., D.D., S.B., M.G., I.T., O.R.-R., and J.A.R. declare no competing interests.